Supreme Court to hear "pay-for-delay" drug case

(Reuters) - The Supreme Court agreed on Friday to decide whether brand-name drug companies may pay money to generic drug rivals to keep their lower-priced products off the market, a practice estimated to cost consumers and the government billions of dollars each year.

photography course melbourne photography classes in pune lsa ifr